Zapata-Ruiz A, De la Cruz-Obregón R, Arboine-Aguirre L, Sierra-Fragoso Á, Palacios-Rodríguez JM

Language: Spanish
References: 10
Page: 208-214
PDF size: 203.21 Kb.

ABSTRACT

Background: Age is an important prognostic factor in patients with acute myocardial infarction.
Objective: To establish the characteristics and prognosis of older adults treated with mechanical reperfusion treatment.
Material and Method: A retrospective analysis including patients in the program code myocardial reperfusion treatment was carried out from January 2016 to December 2017.
Results: There were included 1025 patients; 15.3% older than 75 years. The age range was of 33 to 92 years. The mortality rate was increasing exponentially with higher age (3.4% in patients ≤ 54 years, 6.1% in the group of 55 to 64 years, 9.2% in the group of 65 to 75 years and 15.9% in ≥ 75 years, p ‹ 0.001). In patients older than 75 years, primary angioplasty was the preferred method of reperfusion (77.7%), without finding in this group of patients an increase in the ischemic or hemorrhagic cerebral vascular event. Patients older than 75 years who develop cardiogenic shock had a much higher mortality compared with the younger (17.6%, 28%, 33% vs 56%, respectively; p ‹ 0.001).
Conclusions: Despite the different treatments of reperfusion, mortality remains higher in older adults, mainly by multiple comorbidities and a higher rate of ventricular dysfunction.

REFERENCES

1. Shanmugam VB, Harper R, et al. An overview of PCI in the very elderly. J Geriatr Cardiol 2015;12:174-184.

2. Wang TY, Gutiérrez A, Peterson DE. Percutaneous coronary intervention in the elderly. Nat Rev Cardiol 2011;8:79-90.

3. Ibanez B, James S, Agewall S, et al. 2017 ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation. Eur Heart J 2017;00:1-66.

4. Levine GN, Bates ER et al. 2011 ACCF/AHA/SCAI Guideline for Percutaneous Coronary Intervention J Am Coll Cardiol 2011;58:e44-122.

5. Thiemann DR, Coresh F, Shulman P, et al. Lack of benefit for intravenous thrombolysis in patients with myocardial infarction who are older than 75 years. Circulation 2000;101:2239-2246.

6. Capodanno D, Angiolillo DJ. Antithrombotic therapy in the elderly. J Am Coll Cardiol 2010;56:1683-92.

7. Campo C, Ferreira RP, Teixeira C, et al. Percutaneous coronary intervention using transradial access in elderly vs. nonelderly patients. Rev Bras Cardiol Invasiva 2013;21(1):36-42.

8. Hsieh V, Jolly SS. Should radial access be the preferred approach in the elderly? Rev Bras Cardiol Invasiva 2012;20(1).

9. Sim WL, Mutha V, et al. Clinical characteristics and outcomes of octogenarians presenting with ST elevation myocardial infarction in the Australian population. World J Cardiol 2017 May 26;9(5):437-441.

10. Guagliumi G, Stone GW, Cox DA, et al. Outcome in elderly patients undergoing primary coronary intervention for acute myocardial infarction, results from the Controlled Abciximab and Device Investigation to Lower Late Angioplasty Complications (CADILLAC) Trial. Circulation 2004;110:1598-1604.